Matthew P. Ottmer

2017

In 2017, Matthew P. Ottmer earned a total compensation of $1.8M as Former Chief Operating Officer at Momenta Pharmaceuticals, a 24% increase compared to previous year.

Compensation breakdown

Option Awards$460,920
Salary$153,316
Stock Awards$452,400
Other$725,839
Total$1,792,475

Ottmer received $725.8K in other compensation, accounting for 40% of the total pay in 2017.

Ottmer also received $460.9K in option awards, $153.3K in salary and $452.4K in stock awards.

Rankings

In 2017, Matthew P. Ottmer's compensation ranked 6,049th out of 14,666 executives tracked by ExecPay. In other words, Ottmer earned more than 58.8% of executives.

ClassificationRankingPercentile
All
6,049
out of 14,666
59th
Division
Manufacturing
2,221
out of 5,772
62nd
Major group
Chemicals And Allied Products
702
out of 2,075
66th
Industry group
Drugs
541
out of 1,731
69th
Industry
Biological Products, Except Diagnostic Substances
99
out of 313
68th
Source: SEC filing on April 27, 2018.

Ottmer's colleagues

We found five more compensation records of executives who worked with Matthew P. Ottmer at Momenta Pharmaceuticals in 2017.

2017

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2017

Santiago Arroyo

Momenta Pharmaceuticals

Chief Medical Officer

2017

Ganesh Kaundinya

Momenta Pharmaceuticals

Chief Operating Officer

2017

Bruce Leicher

Momenta Pharmaceuticals

General Counsel

2017

Scott Storer

Momenta Pharmaceuticals

Chief Financial Officer

You may also like